1. Home
  2. ACOG vs ALTO Comparison

ACOG vs ALTO Comparison

Compare ACOG & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • ALTO
  • Stock Information
  • Founded
  • ACOG 2000
  • ALTO 2003
  • Country
  • ACOG Canada
  • ALTO United States
  • Employees
  • ACOG N/A
  • ALTO N/A
  • Industry
  • ACOG
  • ALTO Major Chemicals
  • Sector
  • ACOG
  • ALTO Industrials
  • Exchange
  • ACOG Nasdaq
  • ALTO Nasdaq
  • Market Cap
  • ACOG 80.3M
  • ALTO 90.3M
  • IPO Year
  • ACOG N/A
  • ALTO N/A
  • Fundamental
  • Price
  • ACOG $10.35
  • ALTO $1.20
  • Analyst Decision
  • ACOG Strong Buy
  • ALTO Strong Buy
  • Analyst Count
  • ACOG 1
  • ALTO 1
  • Target Price
  • ACOG $20.00
  • ALTO $5.50
  • AVG Volume (30 Days)
  • ACOG 62.9K
  • ALTO 263.3K
  • Earning Date
  • ACOG 08-14-2025
  • ALTO 08-05-2025
  • Dividend Yield
  • ACOG N/A
  • ALTO N/A
  • EPS Growth
  • ACOG N/A
  • ALTO N/A
  • EPS
  • ACOG N/A
  • ALTO N/A
  • Revenue
  • ACOG $2,928,654.00
  • ALTO $951,169,000.00
  • Revenue This Year
  • ACOG N/A
  • ALTO N/A
  • Revenue Next Year
  • ACOG N/A
  • ALTO $7.68
  • P/E Ratio
  • ACOG N/A
  • ALTO N/A
  • Revenue Growth
  • ACOG N/A
  • ALTO N/A
  • 52 Week Low
  • ACOG $3.75
  • ALTO $0.76
  • 52 Week High
  • ACOG $11.54
  • ALTO $2.05
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • ALTO 67.97
  • Support Level
  • ACOG N/A
  • ALTO $1.19
  • Resistance Level
  • ACOG N/A
  • ALTO $1.29
  • Average True Range (ATR)
  • ACOG 0.00
  • ALTO 0.06
  • MACD
  • ACOG 0.00
  • ALTO 0.00
  • Stochastic Oscillator
  • ACOG 0.00
  • ALTO 93.75

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About ALTO Alto Ingredients Inc.

Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.

Share on Social Networks: